Skip to Content
Merck
CN

432881

4-(Chloromethyl)phenyl acetate

98%

Synonym(s):

α-Chloro-p-cresol acetate, 4-Acetoxybenzyl chloride, p-(Chloromethyl)phenyl acetate, p-Acetoxybenzyl chloride

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

Linear Formula:
CH3CO2C6H4CH2Cl
CAS Number:
39720-27-9
Molecular Weight:
184.62
NACRES:
NA.22
PubChem Substance ID:
24867105
UNSPSC Code:
12352100
MDL number:
MFCD00209564

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

4-(Chloromethyl)phenyl acetate, 98%

InChI

1S/C9H9ClO2/c1-7(11)12-9-4-2-8(6-10)3-5-9/h2-5H,6H2,1H3

SMILES string

CC(=O)Oc1ccc(CCl)cc1

InChI key

OKRCXSCDWKJWSW-UHFFFAOYSA-N

assay

98%

form

liquid

refractive index

n20/D 1.53 (lit.)

bp

240 °C (lit.)

density

1.201 g/mL at 25 °C (lit.)

functional group

chloro
ester

Quality Level

200

Related Categories

Application

4-(Chloromethyl)phenyl acetate may be used as reagent in 4-(chloromethyl)phenyl acetate assay.

pictograms

CorrosionExclamation mark
GHS05,GHS07

signalword

Danger

Hazard Classifications

Acute Tox. 4 Oral - Skin Corr. 1B - Skin Sens. 1

Storage Class

8A - Combustible corrosive hazardous materials

wgk

WGK 3

flash_point_f

235.4 °F - closed cup

flash_point_c

113 °C - closed cup

ppe

Faceshields, Gloves, Goggles, type ABEK (EN14387) respirator filter

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0000490100
0000490100
0000444190
0000444190
0000347347

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Determination of paraoxonase 1 status without the use of toxic organophosphate substrates.
Rebecca J Richter et al.
Circulation. Cardiovascular genetics, 1(2), 147-152 (2009-12-25)
Michael Maes et al.
Metabolic brain disease, 36(3), 509-521 (2021-01-08)
Current diagnoses of mood disorders are not cross validated. The aim of the current paper is to explain how machine learning techniques can be used to a) construct a model which ensembles risk/resilience (R/R), adverse outcome pathways (AOPs), staging, and
Michael Maes et al.
Molecular neurobiology, 57(5), 2333-2345 (2020-02-11)
Accumulating evidence suggests that TNF-α-mediated immune-neurotoxicity contributes to cognitive impairments and the overall severity of schizophrenia (OSOS). There are no data whether peripheral IL-6 and IL-4 may affect the phenome of schizophrenia above and beyond the effects of TNF-α and
Michael Maes et al.
Molecular neurobiology, 56(9), 6626-6644 (2019-03-27)
Although, staging models gained momentum to stage define affective disorders, no attempts were made to construct mathematical staging models using clinical and biomarker data in patients with major depression and bipolar disorder. The aims of this study were to use
Michael Maes et al.
Neurotoxicity research (2018-05-08)
Accumulating evidence shows that nitro-oxidative pathways play an important role in the pathophysiology of major depressive disorder (MDD) and bipolar disorder (BD) and maybe anxiety disorders. The current study aims to examine superoxide dismutase (SOD1), catalase, lipid hydroperoxides (LOOH), nitric
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service